NASDAQ:ENVB | Free Cash Flow | Enveric Biosciences, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2010-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$2.26M
2025-12-31-$1.78M
2025-03-31-$2.39M
2024-12-31-$1.31M
2024-03-31-$2.6M
2023-12-31-$1.75M-$15.00-$1.75M
2023-03-31-$5.14M$5,169.00-$5.14M
2022-12-31-$3.46M$6,193.00-$3.47M
2022-03-31-$4.55M$505,507.00-$5.05M
2021-12-31-$4.07M
2021-03-31-$3.16M
2020-12-31-$2.25M
2020-03-31-$893,922.00
2019-12-31$826,296.00
2019-03-31-$984,134.00
2018-12-31-$1M
2018-03-31-$459,564.00
2017-12-31-$941,223.00
2017-03-31-$837,933.00
2016-12-31$293,575.00
2016-03-31-$1.57M
2015-06-30-$842,024.00
2015-03-31-$331,006.00
2014-12-31-$4,041.00
2014-06-30$232,650.00
2014-03-31-$27,779.00
2013-12-31-$435.00
2013-03-31-$12,221.00
2012-12-31-$3,768.00
2012-03-31-$12,145.00
2011-12-31-$4,780.00
2011-03-31-$16,971.00
2010-12-31-$3,034.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$8.14M
2024-12-31-$7.73M
2023-12-31-$14.09M$5,180.00-$14.1M
2022-12-31-$17.15M$584,165.00-$17.73M
2021-12-31-$11.46M$189,719.00-$11.65M
2020-12-31-$3.89M
2019-12-31-$647,860.00
2018-12-31-$2.57M
2017-12-31-$2.74M
2016-12-31-$2.7M
2014-12-31-$43,164.00
2013-12-31-$21,632.00
2012-12-31-$24,850.00
2011-12-31-$30,346.00
2010-12-31-$40,666.00